Kuo-Hsiang Chuang – 研究成果 — 臺北醫學大學

查看斯高帕斯 (Scopus) 概要

電子郵件khchuangtmu.edutw

h-index

每年研究成果

如果您對這些純文本內容做了任何改變，很快就會看到。

53 文章
3 評論/辯論
2 回顧型文獻

3結果

篩選

2020
Corrigendum to“Isoindoline scaffold-based dual inhibitors of HDAC6 and HSP90 suppressing the growth of lung cancer in vitro and in vivo”[Eur. J. Med. Chem. 190 (2020 Mar 15) 112086] (European Journal of Medicinal Chemistry (2020) 190, (S0223523420300532), (10.1016/j.ejmech.2020.112086))
Ojha, R., Nepali, K., Chen, C. H., Chuang, K. H., Wu, T. Y., Lin, T. E., Hsu, K. C., Chao, M. W., Lai, M. J., Lin, M. H., Huang, H. L., Chang, C. D., Pan, S. L., Chen, M. C. & Liou, J. P., 9月 1 2020, 於: European Journal of Medicinal Chemistry. 201, 112404.
研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審
Corrigendum to “N-alkyl-hydroxybenzoyl anilide hydroxamates as dual inhibitors of HDAC and HSP90, downregulating IFN-γ induced PD-L1 expression”[Eur. J. Med. Chem. 2020 Jan 1;185:111725] (European Journal of Medicinal Chemistry (2020) 185, (S0223523419308773), (10.1016/j.ejmech.2019.111725))
Mehndiratta, S., Lin, M. H., Wu, Y. W., Chen, C. H., Wu, T. Y., Chuang, K. H., Chao, M. W., Chen, Y. Y., Pan, S. L., Chen, M. C. & Liou, J. P., 8月 1 2020, 於: European Journal of Medicinal Chemistry. 199, 112406.
研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審

開啟存取
1 引文斯高帕斯（Scopus）
2018
Erratum: Author Correction: Poly-protein G-expressing bacteria enhance the sensitivity of immunoassays (Scientific reports (2017) 7 1 (989))
Hao, W. R., Chen, M., Chen, Y. J., Su, Y. C., Cheng, C. M., Hsueh, H. Y., Kao, A. P., Hsieh, Y. C., Chang, J., Tseng, M. Y. & Chuang, K. H., 3月 6 2018, 於: Scientific Reports. 8, 1, 1 p., 4256.
研究成果: 雜誌貢獻 › 評論/辯論 › 同行評審

開啟存取